STOCKHOLDERS' EQUITY (Tables)

12 Months Ended

Jun. 30, 2014

The Company accounted for its options to employees and directors under the fair value method in accordance with ASC 718. A summary of the Company's share option activity for options granted to employees and directors under the Plans is as follows:

	Year ended June 30, 2014
	Number			Weighted Average Exercise Price		Weighted Average Remaining Contractual Terms (in years)		Aggregate Intrinsic Value Price
Options outstanding at beginning of period		1,958,156		$	4.03
Options exercised		(15,000	)	$	0.83
Options forfeited		(81,057	)	$	11.59
Options outstanding at end of the period		1,862,099		$	3.73		3.13	$	1,046
Options exercisable at the end of the period		1,862,099		$	3.73		3.13	$	1,046
Options vested		1,862,099		$	3.73		3.13	$	1,046

Schedule of Stock Option and Warrant Activity

A summary of the Company's activity related to options and warrants to consultants is as follows:

	Year ended June 30, 2014
	Number			Weighted Average Exercise Price		Weighted Average Remaining Contractual Terms (in years)		Aggregate Intrinsic Value Price
Options and warrants outstanding at beginning of period		315,500		$	4.44
Options granted		3,000		$	0.00
Options and warrants exercised		(66,500	)	$	1.39
Options and warrants outstanding at end of the period		252,000		$	5.19		3.96	$	331
Options and warrants exercisable at the end of the period		251,000		$	5.21		3.93	$	328
Options and warrants vested and expected to vest		252,000		$	5.19		3.96	$	331

Summary of Options and Warrants Outstanding

The following table sets forth a summary of all the warrants and options outstanding as of June 30, 2014:

Warrants / Options	Exercise Price per Share		Options and Warrants for Common Stock		Options and Warrants Exercisable		Weighted Average Remaining Contractual Terms(in years)
Warrants:	$	1.40		474,322		474,322		0.82
	$	1.50		878,174		878,174		0.06
	$	1.60		131,221		131,221		0.78
	$	1.80		727,401		727,401		0.30
	$	1.90		43,103		43,103		0.08
	$	4.20		5,060,000		5,060,000		2.09
	$	5.00		3,219,983		3,219,983		3.22
Total warrants				10,534,204		10,534,204

Options:	$	0.00		101,000		100,000		5.19
	$	0.62		398,500		398,500		4.25
	$	1.04		30,000		30,000		4.16
	$	2.97		20,000		20,000		3.86
	$	3.50		900,000		900,000		2.58
	$	3.72		15,000		15,000		2.49
	$	3.80		16,050		16,050		2.53
	$	4.00		42,500		42,500		2.30
	$	4.38 - $ 4.40		417,299		417,299		3.28
	$	6.80		36,250		36,250		3.37
	$	8.20		30,000		30,000		2.40
	$	20.00		107,500		107,500		2.88
Total options				2,114,099		2,113,099
Total warrants and options				12,648,303		12,647,303

Options and warrants [Member]

Stockholders Equity Note [Line Items]

Schedule of Stock-based Compensation Expenses

Compensation expenses related to options and warrants granted to consultants were recorded as follows:

	Year ended June 30,
	2014		2013		2012

Research and development expenses	$	11	$	26	$	19
General and administrative expenses				-		37
	$	11	$	26	$	56

Restricted stock units [Member]

Stockholders Equity Note [Line Items]

Schedule of Unvested Restricted Stock Units

The following table summarizes the activities for unvested restricted stock units granted to employees and directors for the year ended June 30, 2014:

	Number

Unvested at the beginning of period		1,660,525
Granted		1,256,940
Forfeited		(44,183	)
Vested		(1,283,850	)
Unvested at the end of the period		1,589,432
Expected to vest after June 30, 2014		1,522,024

Schedule of Stock-based Compensation Expenses

Compensation expenses related to restricted stock units granted to employees and directors were recorded as follows:

	Year ended June 30,
	2014		2013		2012
Research and development expenses	$	1,172	$	711	$	1,163
General and administrative expenses		4,390		1,529		3,487
	$	5,562	$	2,240	$	4,650

Consultant restricted stock units [Member]

Stockholders Equity Note [Line Items]

Schedule of Unvested Restricted Stock Units

The following table summarizes the activities for unvested restricted stock units and restricted stock granted to consultants for the year ended June 30, 2014:

	Number
Unvested at the beginning of period		-
Granted		84,565
Vested		(69,315	)
Unvested at the end of the period		15,250

Schedule of Stock-based Compensation Expenses

Compensation expenses related to restricted stock units granted to consultants were recorded as follows:

	Year ended June 30,
	2014		2013		2012
Research and development expenses	$	201	$	255	$	201
General and administrative expenses		77		278		20
	$	278	$	533	$	221